✦ LIBER ✦

CMF and mitoxantrone in elderly patients with advanced breast cancer. A randomized phase II study

✍ Scribed by M.A. Nooij; E. Steenland; L.V.A.M. Beex; B. van de Bos; L. Ruiter; J.C.J.M. Haes

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of liposome-complexed mit

✍ B.C. Pestalozzi; A. Vass; H. Adam; D.H. Horber; R.A. Schwendener; Chr. Sauter 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 137 KB

Phase II study of mitoxantrone, 5-fluoro

✍ Serafina Mammoliti; Laura Merlini; Cinzia Caroti; Luigi Gallo 📂 Article 📅 1996 🏛 Springer US 🌐 English ⚖ 314 KB

Mitoxantrone/prednimustine combination t

✍ H. Schmid; C. Manegold; M. Kaufmann; F. Kubli 📂 Article 📅 1986 🏛 Springer-Verlag 🌐 English ⚖ 133 KB

Combined cytotoxic and endocrine therapy

✍ H.T. Mouridsen; C. Rose; E. Engelsmann; R. Sylvester; N. Rotmensz 📂 Article 📅 1985 🏛 Elsevier Science 🌐 English ⚖ 581 KB

Phase II evaluation of mitoxantrone plus

✍ Joshua O. Atiba; Stephanie J. Green; Harry E. Hynes; C. Kent Osborne; Thomas P. 📂 Article 📅 1994 🏛 Springer US 🌐 English ⚖ 266 KB

Dose intensification of mitoxantrone in

✍ Francesco Di Costanzo; Andrea Sdrobolini; Luigi Manzione; Domenico Bilancia; Lui 📂 Article 📅 1999 🏛 Springer US 🌐 English ⚖ 42 KB